Flossbach Von Storch SE acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 565 shares of the medical equipment provider's stock, valued at approximately $280,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Castleark Management LLC grew its stake in Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after purchasing an additional 2,990 shares during the period. Arlington Trust Co LLC grew its stake in Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after purchasing an additional 191 shares during the period. Aaron Wealth Advisors LLC grew its stake in Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock worth $1,243,000 after purchasing an additional 78 shares during the period. Ewing Morris & Co. Investment Partners Ltd. purchased a new stake in Intuitive Surgical in the fourth quarter worth $454,000. Finally, Whalerock Point Partners LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth $209,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the company. Robert W. Baird reduced their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Piper Sandler dropped their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a "buy" rating in a report on Monday, April 14th. Royal Bank Of Canada cut their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $592.59.
Read Our Latest Stock Analysis on Intuitive Surgical
Intuitive Surgical Stock Up 0.2%
NASDAQ:ISRG traded up $0.83 during mid-day trading on Wednesday, hitting $528.13. 1,380,875 shares of the company traded hands, compared to its average volume of 1,670,939. The stock's fifty day moving average price is $537.77 and its 200-day moving average price is $536.93. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00. The firm has a market cap of $189.29 billion, a price-to-earnings ratio of 77.44, a price-to-earnings-growth ratio of 5.67 and a beta of 1.64.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the prior year, the firm posted $1.50 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Insider Activity
In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director owned 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president directly owned 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last ninety days. Company insiders own 0.70% of the company's stock.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.